.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
In House is stocked at 566 licensed dispensaries across Massachusetts, Illinois, and 7 other states, 208 of them in Massachusetts, with the deepest coverage in Worcester, Boston, Northampton, Fall River, and Springfield. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In House’s category mix in July 2026 tilted toward Edible at 40.57% share with year-over-year growth of 40.93% and month-over-month growth of 7.42%, while Vapor Pens held 30.97% share but contracted year-over-year by 24.94% despite a 5.66% month-over-month uptick. Flower slid to 23.11% share with a 38.29% year-over-year decline and a 3.15% month-over-month drop, contrasted by Pre-Roll’s small 3.72% share but sharp gains of 204.55% year-over-year and 51.03% month-over-month. With Concentrates at 1.63% share growing 13.15% year-over-year and 3.56% month-over-month, the portfolio shift — alongside a 17.34% year-over-year decrease in average price and an overall brand sales change of -9.22% year-over-year versus +5.998% over 24 months — implies a deliberate pivot toward lower-priced, faster-turning formats to stabilize volume.
These shifts position In House to compete more on accessibility within Edible and Pre-Roll, where rising shares and double- to triple-digit growth rates can offset Vapor Pens and Flower declines; specifically, Edible’s 40.57% share paired with a 7.42% month-over-month gain and Pre-Roll’s 51.03% month-over-month surge suggest basket-entry roles, while Vapor Pens’ 24.94% year-over-year contraction and Flower’s 38.29% year-over-year drop indicate deprioritization. Holding rank 3 in Edible in Maryland and posting a 5.66% month-over-month rise in Vapor Pens alongside a 3.15% month-over-month decline in Flower implies retail shelf strategy skewing toward edible-first merchandising with selective pen promotions, aiming to convert traffic into repeat purchases despite a 17.34% year-over-year price compression.
Competitive Landscape
In House is currently ranked #3 in MD Edible, up 3 positions year over year from #6, and up 1 position versus three months ago from #4; this coincides with a peak rank of #3 reached in July 2026 and puts the brand within 2 ranks of Incredibles, which climbed from #3 to #1 with 26.0% YoY sales growth, while edging ahead of Wyld, which slid from #1 to #4 alongside an 18.0% YoY sales decline. With Betty's Eddies holding #2 on 6.6% YoY growth and Curio Wellness steady at #5 with an 11.1% YoY contraction, the combination of a 3-rank YoY gain and a 1-rank quarter-on-quarter lift implies In House is converting share from weakening incumbents rather than relying solely on category expansion.
Notable Products
Peach Mango Fast Acting Gummies 10-Pack (100mg) posted the largest move in July 2026 with +39.7% MoM to rank 2, while CBD/THC 5:1 Blood Orange Fast Acting Gummies 10-Pack (500mg CBD, 100mg THC) held rank 1 with +11.3% MoM; in contrast, Cherry Lemonade Fast Acting Gummies 20-Pack (100mg) slipped -2.6% MoM at rank 7. Cherry Lemonade Fast Acting Gummies 10-Pack (100mg) advanced +13.6% MoM at rank 3, and Watermelon Fast Acting Gummies 10-Pack (100mg) gained +15.4% MoM at rank 6, with eight of the top ten SKUs concentrated in Edibles. The only Pre-Roll entrant, Blueberry Crumble Infused Pre-Roll (0.75g), sat at rank 10 with $48,264 in July 2026 sales while the CBD/THC/CBN 3:2:1 Blueberry Dreams Nano Gummies 10-Pack (150mg CBD, 100mg THC, 50mg CBN) climbed +23.4% MoM at rank 4, indicating cannabinoid-blend formats are scaling faster than size-variant extensions. The pattern implies In House’s commercial direction is consolidating around fast-acting edible formats with functional cannabinoid ratios, with minimal traction outside Edibles.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
